TABLE 12.
Medication classes involved in potentially preventable DRAs related to treatment safety (N = 51).
| Medication classes | No. | Medications |
|---|---|---|
| Anti-inflammatory and antirheumatic products | 12 | ibuprofen (4), diclofenac (3), meloxicam (2), nimesulide (2), naproxen (1) |
| Antithrombotic agents | 10 | warfarin (6), acetylsalicylic acid (3), nadroparin (1) |
| Drugs used in diabetes | 6 | insulin (4), glimepiride (2) |
| Cardiac therapy | 4 | digoxin (2), amiodarone (2) |
| Diuretics | 4 | furosemide (3), amiloride (1) |
| Psycholeptics | 4 | tiapride (2), haloperidol (1), zolpidem (1) |
| Analgesics | 2 | tramadol (2) |
| Beta blocking agents | 2 | metoprolol (1), bisoprolol (1) |
| Agents acting on the renin-angiotensin system | 1 | perindopril |
| Antihypertensives | 1 | doxazosin |
| Anti-parkinson drugs | 1 | levodopa |
| Calcium channel blockers | 1 | verapamil |
| Mineral supplements | 1 | potassium chloride |
| Psychoanaleptics | 1 | dosulepin |
| Sex hormones and modulators of the genital system | 1 | hormonal contraceptive |
DRA, Drug-related hospital admission.